St. Jude Research

2017 Archive

Heme synthesis linked with acute myeloid leukemia
Heme synthesis linked with acute myeloid leukemia
Research

Blood's oxygen transporter revealed as power source for aggressive pediatric cancer

 John Schuetz, PhD

Read how the oncogene MYCN hijacks an oxygen-carrying component of hemoglobin to feed and grow aggressive AML in children.

ASH 2017: Preliminary results show gene therapy gains in X-linked SCID
ASH 2017: Preliminary results show gene therapy gains in X-linked SCID
Research

ASH 2017: Preliminary results show gene therapy gains in SCID

 Ewelina Mamcarz, MD

Gene therapy for X-linked SCID resulted in the development of T cell, B cell and natural killer cells without side effects. Read more about the research.

ASH 2017: The role of GATA3 in Ph-like acute lymphoblastic leukemia
ASH 2017: The role of GATA3 in Ph-like acute lymphoblastic leukemia
Research

ASH 2017: GATA3 in Ph-like acute lymphoblastic leukemia

 Jun Yang, PhD

Jun J. Yang, PhD, shares research presented at ASH that highlights the role the GATA3 oncogene plays in a high-risk subset of acute lymphoblastic leukemia.

ASH 2017: Learning, networking and recruiting at hematology meeting
ASH 2017: Learning, networking and recruiting at hematology meeting
Outreach

ASH 2017: Learning, networking and recruiting at the annual hematology meeting

 Mitchell Weiss, MD, PhD

The annual American Society of Hematology (ASH) meeting offers St. Jude clinicians and researchers the opportunity to learn, network and recruit. Read more.

The St. Jude equation: A better method of calculating kidney function
The St. Jude equation: A better method of calculating kidney function
Clinical

The St. Jude Equations: A better method of calculating kidney function

 Mary Powers

Learn about new equations to estimate kidney function in young cancer patients more quickly and accurately.

ASH17: Research on TP53 gene variations presented at first ALL session
ASH17: Research on TP53 gene variations presented at first ALL session
Research

ASH 2017: Research on TP53 gene variations featured in first ALL session

 Jun Yang, PhD

Jun J. Yang, PhD, offers highlights of the first ALL session at the American Society of Hematology (ASH) meeting, including his work on TP53. Read more.

Math helps biologist calculate variance of blood progenitor cells
Math helps biologist calculate variance of blood progenitor cells
Research

Math helps biologist calculate variance of blood progenitor cells

 Miguel Ganuza, PhD

Find out how a researcher applied statistical analysis to chart variance and better understand how childhood leukemia develops.

Sickle cell study on path to improving therapies for children and adults
Sickle cell study on path to improving therapies for children and adults
Research

Sickle cell study on path to improving therapies for children and adults

 Jane Hankins, MD

The Sickle Cell Clinical Research and Intervention Program uses data to determine therapies for children and adults. Learn more.

Trio’s award awakens effects of sleep and sleep patterns
Trio’s award awakens effects of sleep and sleep patterns
Clinical

Trio’s award awakens effects of sleep and sleep patterns

 Valerie Crabtree, PhD

Find out how poor sleep hampers treatment of young children with cancer

Brain studies provide treatment clues in unexpected fields
Brain studies provide treatment clues in unexpected fields
Research

Brain studies provide treatment clues in unexpected fields

 Stanislav Zakharenko, MD, PhD

Research shows possible path to restoring critical regions of the brain involved with hearing loss by limiting a neuromodulator in the auditory thalamus.